XML 18 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
Interim Condensed Consolidated Statements Of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Additional Paid-In Capital
Class A Common Stock [Member]
Retained Earnings
Accumulated Other Comprehensive Loss
Total Stockholders' Equity - Dolby Laboratories, Inc.
Noncontrolling Interest
Beginning balance (in shares) at Sep. 30, 2022   94,000            
Beginning balance at Sep. 30, 2022 $ 2,251,020   $ 0   $ 2,297,730 $ (51,641) $ 2,246,183 $ 4,837
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 79,448       79,375   79,375 73
Other comprehensive income, net of tax 20,069         19,766 19,766 303
Distributions to noncontrolling interest (266)             266
Stock-based compensation expense 31,240   31,240       31,240  
Capitalized stock-based compensation expense 341   341       341  
Repurchase of common stock (in shares)   (1,000)            
Repurchase of common stock (49,412)   (17,533)   (31,878)   (49,412)  
Cash dividends declared and paid on common stock (25,869)       (25,869)   (25,869)  
Common stock issued under employee stock plans 10,954 $ 2 10,952       10,954  
Tax withholdings on vesting of restricted stock (25,000)     $ (25,000)     (25,000)  
Ending balance (in shares) at Dec. 30, 2022   95,000            
Ending balance at Dec. 30, 2022 2,292,525   0   2,319,358 (31,875) 2,287,578 4,947
Beginning balance (in shares) at Sep. 29, 2023   94,000            
Beginning balance at Sep. 29, 2023 2,372,184   0   2,391,990 (36,984) 2,355,100 17,084
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 67,581       66,981   66,981 600
Other comprehensive income, net of tax 15,696         15,556 15,556 140
Distributions to noncontrolling interest (1,047)             1,047
Stock-based compensation expense 31,894   31,894       31,894  
Capitalized stock-based compensation expense $ 95   95       95  
Repurchase of common stock (in shares) (967,789) (1,000)            
Repurchase of common stock $ (80,002)   (16,087)   (63,914)   (80,002)  
Cash dividends declared and paid on common stock (28,552)       (28,552)   (28,552)  
Common stock issued under employee stock plans 18,301 $ 1 18,300       18,301  
Tax withholdings on vesting of restricted stock (34,562)     $ (34,562)     (34,562)  
Deconsolidation of subsidiary 0       677   677 (677)
Equity issued in connection with business combination 722   360       360 362
Ending balance (in shares) at Dec. 29, 2023   94,000            
Ending balance at Dec. 29, 2023 $ 2,362,310   $ 0   $ 2,367,182 $ (21,428) $ 2,345,848 $ 16,462